BioCryst Pharmaceuticals, Inc. (BCRX)
9.845
+0.16
(+1.70%)
USD |
NASDAQ |
Aug 25, 16:00
9.845
0.00 (0.00%)
After-Hours: 17:05
BioCryst Pharmaceuticals 1 Year Total Returns (Daily) : 13.08% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 13.08% |
| August 21, 2026 | 13.96% |
| August 20, 2026 | 15.27% |
| August 19, 2026 | 21.62% |
| August 18, 2026 | 15.75% |
| August 17, 2026 | 18.76% |
| August 14, 2026 | 15.27% |
| August 13, 2026 | 15.01% |
| August 12, 2026 | 26.83% |
| August 11, 2026 | 26.10% |
| August 10, 2026 | 18.55% |
| August 07, 2026 | 12.34% |
| August 06, 2026 | 8.14% |
| August 05, 2026 | 8.49% |
| August 04, 2026 | 3.32% |
| August 03, 2026 | 10.82% |
| July 31, 2026 | 10.32% |
| July 30, 2026 | 12.41% |
| July 29, 2026 | 17.80% |
| July 28, 2026 | 17.92% |
| July 27, 2026 | 12.05% |
| July 24, 2026 | 9.24% |
| July 23, 2026 | 8.94% |
| July 22, 2026 | 9.94% |
| July 21, 2026 | 10.56% |
| Date | Value |
|---|---|
| July 20, 2026 | 5.81% |
| July 17, 2026 | 6.78% |
| July 16, 2026 | 6.00% |
| July 15, 2026 | 7.91% |
| July 14, 2026 | 8.71% |
| July 13, 2026 | 13.13% |
| July 10, 2026 | 17.68% |
| July 09, 2026 | 18.32% |
| July 08, 2026 | 26.39% |
| July 07, 2026 | 25.46% |
| July 06, 2026 | 13.76% |
| July 02, 2026 | 9.09% |
| July 01, 2026 | 7.22% |
| June 30, 2026 | 11.61% |
| June 29, 2026 | 2.03% |
| June 26, 2026 | 2.90% |
| June 25, 2026 | 1.64% |
| June 24, 2026 | 0.70% |
| June 23, 2026 | -6.05% |
| June 22, 2026 | -9.50% |
| June 18, 2026 | -9.74% |
| June 17, 2026 | -10.23% |
| June 16, 2026 | -13.31% |
| June 15, 2026 | -12.63% |
| June 12, 2026 | -16.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Amgen, Inc. | 55.28% |
| Vertex Pharmaceuticals, Inc. | 38.59% |
| Agenus, Inc. | 69.69% |
| Anika Therapeutics, Inc. | 121.1% |
| Imunon, Inc. | -75.54% |